| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5871209 | Primary Care Diabetes | 2016 | 4 Pages |
Abstract
We aimed to investigate the association between incretin-based therapies and 1-year change in depressive symptoms in a cohort of 1735 patients with newly diagnosed type 2 diabetes. The incretin group experienced significant reduction in depressive symptoms compared to controls. This was independent of HbA1c and may be mediated by an anti-inflammatory mechanism.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
C.D. Moulton, J.C. Pickup, S.A. Amiel, K. Winkley, K. Ismail,